Overwijk, Willem W.
Nektar Therapeutics,
United States
2025 Rank: 92,652
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,701 out of 166,615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 92,652 | 101,114 |
| Total Cites | 862 | 887 |
| H-index | 15 | 16 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 84 | 84 |
| Number of Single+First+Last Authored Papers | 32 | 32 |
| Total Cites to Single+First+Last Authored Papers | 224 | 225 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 798 | 819 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.08 |
| Self-Citation Percentage |
2.82%
|
|
Overwijk, Willem W.
The University of Texas MD Anderson Cancer Center,
United States
2024 Rank: 148,851
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2,812 out of 157,372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 148,851 | 172,902 |
| Total Cites | 822 | 854 |
| H-index | 15 | 15 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 49 | 49 |
| Number of Single+First+Last Authored Papers | 30 | 30 |
| Total Cites to Single+First+Last Authored Papers | 162 | 163 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 768 | 796 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.07 |
| Self-Citation Percentage |
3.75%
|
|
Overwijk, Willem W.
The University of Texas MD Anderson Cancer Center,
United States
2023 Rank: 88,329
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,907 out of 147,556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 88,329 | 96,735 |
| Total Cites | 1,048 | 1,103 |
| H-index | 16 | 17 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 76 | 76 |
| Number of Single+First+Last Authored Papers | 32 | 32 |
| Total Cites to Single+First+Last Authored Papers | 237 | 243 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 959 | 997 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.11 |
| Self-Citation Percentage |
4.99%
|
|
Overwijk, Willem W.
University of Texas MD Anderson Cancer Center,
United States
2022 Rank: 42,320
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,084 out of 138,599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 42,320 | 46,251 |
| Total Cites | 1,278 | 1,364 |
| H-index | 20 | 20 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 12 | 12 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 80 | 83 |
| Number of Single+First+Last Authored Papers | 32 | 32 |
| Total Cites to Single+First+Last Authored Papers | 303 | 316 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,157 | 1,217 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.12 |
| Self-Citation Percentage |
6.30%
|
|
Overwijk, Willem W.
Nektar Therapeutics,
United States
2021 Rank: 52,232
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,206 out of 127,911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 52,232 | 57,896 |
| Total Cites | 1,812 | 1,930 |
| H-index | 23 | 24 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 12 | 12 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 106 | 112 |
| Number of Single+First+Last Authored Papers | 31 | 31 |
| Total Cites to Single+First+Last Authored Papers | 393 | 412 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,616 | 1,701 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.13 |
| Self-Citation Percentage |
6.11%
|
|
Overwijk, Willem W.
University of Texas MD Anderson Cancer Center,
United States
2020 Rank: 65,016
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,404 out of 108,509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 65,016 | 67,814 |
| Total Cites | 1,155 | 1,253 |
| H-index | 17 | 19 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 9 | 9 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 84 | 94 |
| Number of Single+First+Last Authored Papers | 30 | 30 |
| Total Cites to Single+First+Last Authored Papers | 247 | 265 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,030 | 1,097 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.14 |
| Self-Citation Percentage |
7.82%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.